Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Alpha adrenergic blockers

  • Be the first to comment

Alpha adrenergic blockers

  1. 1. Dr. K. R. Prabhakar, Resident.
  2. 2. CLASSIFICATION α-Adrenoceptor Antagonists Non-selective block α1 & α2 Selective Miscellaneous •Ergot alkaloids Reversible Irreversible α1-blockers α2-blockers •Phentolamine •Phenoxyben- •Prazosin •Yohimbine zamine •Terazosin •Tolazoline •Idazoxan •Doxazosin (priscoline) •Alfuzosin & Bunazosin •Tamsulosin &Silodosin
  3. 3. General effects of α blockers Blood vessels  α1-blockade→reduces peripheral resistance Fall in BP Postural hypotension  α2-blockade in brain ↑se vasomotor tone.  Block pressor action of adrenaline, fall in BP due toβ2. action- “vasomotor reversal of Dale”  Actions of selective α-agonists supressed.
  4. 4. Heart  Reflex tachycardia due to: fall in mean arterial pressure Blockade of presynaptic α2 receptors- ↑ NA release. Nose: nasal stuffiness Eye: miosis GIT: intestinal motility ↑se Kidney: Hypotension ↓se GFR NA+ & H2O reabsorption
  5. 5. Urinary bladder  α1A blockade- ↓se tone of smooth muscle in trigone, sphincter & prostrate.  Improved urine flow, used in BPH. Reproductive system  Contraction of vas deferens result in ejaculation through α receptors.  Blockade results in impotence.
  6. 6. Irreversible non-selective α- blockers Phenoxybenzamine  Cyclizes spontaneously to highly reactive ethyleniminium intermediate.  Binds covalently to α-receptors- irreversible or nonequilibrium competitive block.  Blockade is slow onset & longer duration (3-4 days).  Also inhibits reuptake of NE.  Shifts blood from pulmonary to systemic circuit.  Shift fluid from extravascular to vascular compartmentrelaxation of postcapillary vessels.
  7. 7. PK  Preferred ROA- i.v.  Lipid soluble penetrates brain.  Mainly excreted through urine in 24 hrs.  Accumulates in adipose tissue on ch. Administration. Dose 20-60 mg/d oral 1mg/kg/1hr slow i.v infusion. Uses Pheochromocytoma, occasionally 2oshock, PVD.
  8. 8. Reversible non-selective α-blockers Tolazoline  Block is modest & short lasting.  Direct vasodilator & stimulates the heart.  Also blocks 5-HT receptors, histamine like gastric secretagouge & Ach like motor action on intestine. SE  N, V, cramps, diarrhoea, nervousness, chills  Tachycardia, Exacerbation of MI, peptic ulcer. Use  PVD  Pulmonary HT of newborn.
  9. 9. Phentolamine  More potent α-blocker than tolazoline.  Other actions are less marked.  Duration of action is shorter (min).  Equally blocks α1 & α2 receptors- NA release ↑sed. Uses  ∆sis & intraop.management of pheochromocytoma. 5mg i.v- B.P falls by 25(D)or35(S)mmHg.  HTN due to clonidine withdrawl, cheese reaction.  Dermal necrosis due to extravasated i.v NA/DA. Given S.C as local infiltration.
  10. 10. Reversible, selective α1- blockers Prazosin  Highly selective α1-blocker , α1: α2 selectivity 1000:1  Fall in BP with only mild tachycardia.  Dilates arterioles more than veins  Postural hypotension occurs as 1st dose effect, minimized by starting with low doses at bed time.  Also inhibits PDE- ↑se cAMP in smooth muscle. PK  Effective orally, BA- 60%.  Highly bound to plasma proteins (α1 acid glycoprotein).
  11. 11.  Metabolized in liver, 1o excreted in bile.  t1/2 – 2-3hrs, effect lasts for 6-8hrs. Uses  Primarily as antihypertensive.  LVF not controlled by diuretics & digitalis.  Raynaud’s disease  BPH  Scorpion sting
  12. 12. Terazosin &Doxazosin  Long acting( t1/212 & 18hr) congener of prazosin.  Used in HTN & BPH as single daily dose. Tamsulosin & Silodosin  Uroselective α1A blocker  α1A –bladder base, prostrate. α1B- blood vessels.  Don't cause significant changes in BP & HR.  t1/2- 6-9hr, MR cap(0.2-0.4 mg) can be taken OD.  Efficacious in Rx of BPH.  SE: retrograde ejaculation, dizziness,, floppy iris syd.  Silodosin weaker(4-8mg/d) but longer acting.
  13. 13. Bunazosin & Alfuzosin  Orally effective α1 blockers similar to prazosin.  Alfuzosin t1/2 4hrs (2.5mgTDS or 10mg SR OD).  CI in hepatic impairment, metabolized in liver.  Bunazosin slightly longer t1/2.  Primarily used in BPH.
  14. 14. α2-receptor blockers Yohimbine  Natural alkaloid from Pausinystalia yohimbe.  No established clinical role. Idazoxan  Has membrane stabilizing action. Ergot alkaloids  Ergotamine & Dihydroergotamine  Competitive α-receptor blockers.  Principal use is migraine.
  15. 15. Uses of α-Blockers Pheochromocytoma  Tumor of adrenal medullary cells-excess Cas.  Cause intermittent or persistent hypertension.  Diagnosed by- ↑se urinary VMA, normetanephrine.  phentolamine test can also be performed. Rx Phenoxybenzamine  Definitive therapy for inoperable or malig.tumors.  Preoperative- orally x 2wks, i.v during surgery as-
  16. 16. 1. Normalizes blood volume & body H2O distribution. 2. During surgery excess release of CAs in to blood. Phentolamine drip can also be used. Hypertension  Selective α1 blocker prazosin is preferred. 2o shock  Fluid loss leads to vasoconstriction.  Should not be given without fluid replacement.
  17. 17. Peripheral vascular disease  Little benefit in Buerger’s disease & int.claudication.  More useful in Reynaud's disease & acrocyanosis where vasoconstriction is prominent.  Prazosin or phenoxybenzamine are useful. CHF  Short term benefit, leads to Na+ & H2O retension. Migraine  Ergotamine more effective
  18. 18. Benign prostrate hypertrophy  Two classes of drugs are available. 1. α1-blockers- ↓ tone of prostrate and bladder neck. 2. 5-α reductase inhibitors: finasteride & dutasteride. arrest growth/reduce size of prostrate.  α1-blockers gives faster and greater symptomatic releif than finasteride.  Effect of α1-blockers decline after several years of use, must be combined with fiasteride.  Terazosin, doxazosin, tamsulosin are preferred.
  19. 19. Side effects of α-blockers  Palpitation  Postural hypotension  Nasal blockade  Diarrhea  Fluid retention  Inhibition of ejaculation & impotence.
  20. 20. Thank you

    Be the first to comment

    Login to see the comments

  • VishwaSM11

    Jan. 14, 2019
  • AnkurVerma174

    Apr. 24, 2019
  • KeshavKrishna7

    Apr. 25, 2019
  • VasanthKulo

    Nov. 17, 2019
  • MidhunMithra1

    Dec. 9, 2019
  • SamsonDebbarma4

    Jan. 1, 2020
  • satyaraj1999

    Mar. 9, 2020
  • divyasreemantula

    Apr. 22, 2020
  • ArathyRNath

    Aug. 13, 2020
  • RanajoySarkar3

    Aug. 28, 2020
  • SilverDoe1

    Oct. 31, 2020
  • AnkithHari

    Nov. 21, 2020
  • AryanAkhil

    Nov. 23, 2020
  • ArunimaRohatgi1

    Dec. 18, 2020
  • RashiYadav17

    Feb. 3, 2021
  • KiranEtubone

    Mar. 14, 2021
  • AjayKumar5301

    Apr. 22, 2021
  • SaiprasadKongari

    May. 7, 2021
  • RajRaushan6

    May. 11, 2021
  • HajjiMassahM

    Jun. 17, 2021

Views

Total views

21,728

On Slideshare

0

From embeds

0

Number of embeds

10

Actions

Downloads

1,012

Shares

0

Comments

0

Likes

53

×